VBI Vaccines reports new CPT issued for a 3-Antigen Hepatitis B
by
Excerpt The American Medical Association (AMA) Current Procedural Terminology (CPT ® ) Panel has established a unique CPT code for the first 3-antigen (S, Pre-S1, Pre-S2) Hepatitis B (HBV) vaccine, developed by VBI Vaccines. This will differentiate this vaccine from other approved, single-antigen HBV vaccines. The 3-antigen HBV vaccine is approved and commercially available in […]
UNICEF signs COVID-19 vaccine supply agreement with Moderna
by
An Advance Purchase Agreement was signed by the COVAX facility following Moderna’s COVID-19 vaccine’s receipt of a WHO Emergency Use Listing (EUL). Under the long-term supply agreement, UNICEF and its procurement partners will have access to 34 million doses of the vaccine for around 92 countries and territories in 2021 on behalf of the COVAX […]
CDC COVID-19 Study Shows mRNA Vaccines Reduce Risk of Infection by 91 Percent for Fully Vaccinated People
by
The extended CDC HEROES-RECOVER study, enrolling healthcare workers, first responders, frontline workers, and other essential workers shows that mRNA COVID-19 vaccines authorized by the FDA lower the risk of infection by 91% for fully vaccinated people and 81% for partially vaccinated people. The study is also one of the first to demonstrate that the mRNA […]
G7 announces pledges of 870 million COVID-19 VACCINE doses, of which at least half to be delivered by the end of 2021
by
COVAX has welcomed G7 leaders’ pledge to share these doses internationally in support of equitable access, building on the momentum of the G20 Global Health Summit and the Gavi COVAX AMC Summit. In so doing, global leaders have reaffirmed their support for COVAX as “the primary route for providing vaccines to the poorest countries.” In […]
BioNTech to Establish Regional Headquarters for South East Asia and First mRNA Manufacturing Facility in Singapore
by
The setting up of its regional headquarters in Singapore is part of BioNTech’s global expansion strategy, and the fully integrated mRNA manufacturing facility will provide regional and global supply capacity of BioNTech’s product candidates. It will also be equipped to address potential pandemic threats in the region. The site, which is expected to be operational […]
ViiV Healthcare Initiates Rolling Submission of New Drug Application with US FDA for Long-Acting Cabotegravir for Prevention of HIV
by
Global specialist HIV company ViiV Healthcare has begun a rolling submission of a new drug application (NDA) with the US FDA for carbotegravir, an investigational, long-acting, injectable drug to prevent HIV. Submissions of regulatory files will begin at the end of this year, focusing initially on countries where clinical trials were conducted. The company will […]
WHO Welcomes Sweden’s Announcement to Share COVID-19 Vaccine Doses with COVAX
by
Sweden has announced a donation of 1 million doses of the AstraZeneca vaccine to COVAX in order to support supplies in low-income countries and ensure populations are able to receive second doses. WHO and its partners are advocating for countries to make similar contributions, and Director-General Dr. Tedros Adhanom Ghebreyesus welcomed the announcement, stating that […]
WHO Lists Additional COVID-19 Vaccine for Emergency Use and Issues Interim Policy Recommendation
by
The Sinopharm COVID-19 vaccine, produced by Beijing Bio-Institute of Biological Products Co Ltd, has been listed for global emergency use. “The addition of this vaccine has the potential to rapidly accelerate COVID-19 vaccineaccess for countries seeking to protect health workers and populations at risk,” said Dr. Mariângela Simão, WHO Assistant-Director General for Access to Health […]
